HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dipeptidyl-Peptidase IV Inhibitors

Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.
Also Known As:
Dipeptidyl-Peptidase 4 Inhibitors; DPP 4 Inhibitor; DPP 4 Inhibitors; DPP IV Inhibitor; DPP IV Inhibitors; Dipeptidyl Peptidase 4 Inhibitors; Dipeptidyl Peptidase IV Inhibitor; Dipeptidyl Peptidase IV Inhibitors; Inhibitor, DPP-4; Inhibitor, DPP-IV; Inhibitor, DPP4; Inhibitor, Dipeptidyl-Peptidase 4; Inhibitor, Dipeptidyl-Peptidase IV; DPP-4 Inhibitor; DPP-4 Inhibitors; DPP-IV Inhibitor; DPP-IV Inhibitors; DPP4 Inhibitor; DPP4 Inhibitors; Dipeptidyl Peptidase 4 Inhibitor; Dipeptidyl-Peptidase 4 Inhibitor; Dipeptidyl-Peptidase IV Inhibitor; Gliptin; Gliptins
Networked: 2325 relevant articles (187 outcomes, 545 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Klein, Thomas: 28 articles (01/2022 - 01/2011)
2. Deacon, Carolyn F: 19 articles (11/2020 - 04/2005)
3. Holst, Jens J: 15 articles (10/2022 - 01/2006)
4. Scheen, André J: 15 articles (11/2021 - 10/2010)
5. Avogaro, Angelo: 15 articles (09/2021 - 07/2013)
6. Watada, Hirotaka: 14 articles (01/2022 - 01/2013)
7. Kim, Dae Jung: 13 articles (05/2022 - 01/2016)
8. Nishie, Wataru: 13 articles (10/2021 - 01/2017)
9. Fadini, Gian Paolo: 13 articles (09/2021 - 07/2013)
10. Kanasaki, Keizo: 13 articles (05/2021 - 11/2013)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Insulin Resistance
3. Hypoglycemia (Reactive Hypoglycemia)
4. Inflammation (Inflammations)
5. Heart Failure

Related Drugs and Biologics

1. Glucagon-Like Peptide 1 (GLP 1)
2. Sitagliptin Phosphate (Januvia)
3. Glucose (Dextrose)
4. Insulin (Novolin)
5. Metformin (Glucophage)
6. Glucagon-Like Peptide-1 Receptor Agonists
7. Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
8. Vildagliptin
9. Hypoglycemic Agents (Hypoglycemics)
10. Linagliptin

Related Therapies and Procedures

1. Therapeutics
2. Glycemic Control
3. Renal Dialysis (Hemodialysis)
4. Oral Administration
5. Hematopoietic Stem Cell Mobilization